Global Nuclear Medicine & Radiopharmaceuticals Market 2022-2028

Garnering a CAGR of 10.4% from 2022 to 2028, the global nuclear medicine & radiopharmaceuticals market is projected to reach worth of USD 17,878 million by 2028.

Nuclear medicine is a medical specialty which uses radioactive tracers to diagnose and treat disease. Specially designed cameras allow doctors to track the circulation, uptake and excretion of these radioactive tracers. Garnering a CAGR of 10.4% from 2022 to 2028, the global nuclear medicine & radiopharmaceuticals market is projected to reach worth of USD 17,878 million by 2028-end, according to a new report The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global nuclear medicine & radiopharmaceuticals market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the nuclear medicine & radiopharmaceuticals industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for nuclear medicine & radiopharmaceuticals can be segmented by product: diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals segment held the largest share of the global nuclear medicine & radiopharmaceuticals market in 2021 and is anticipated to hold its share during the forecast period. Nuclear medicine & radiopharmaceuticals market is further segmented by application: bone metastasis, cardiology, endocrine tumor, hyperthyroidism, lymphoma, oncology, others. Based on region, the nuclear medicine & radiopharmaceuticals market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). By product: - diagnostic radiopharmaceuticals - therapeutic radiopharmaceuticals By application: - bone metastasis - cardiology - endocrine tumor - hyperthyroidism - lymphoma - oncology - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The global nuclear medicine & radiopharmaceuticals market report offers detailed information on several market vendors, including Australian Nuclear Science and Technology Organisation (ANSTO), Bracco S.p.A., Eckert & Ziegler Strahlen- und Medizintechnik AG, ECZACIBASI-MONROL Nuclear Products Co., IBA Molecular (IBAM), IRE - IRE ELiT, Jubilant Life Sciences Ltd., Lantheus Holdings, Inc., Nordion Inc, NTP Radioisotopes SOC Ltd., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Scope of the Report - To analyze and forecast the market size of the global nuclear medicine & radiopharmaceuticals market. - To classify and forecast the global nuclear medicine & radiopharmaceuticals market based on product, application, region. - To identify drivers and challenges for the global nuclear medicine & radiopharmaceuticals market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global nuclear medicine & radiopharmaceuticals market. - To identify and analyze the profile of leading players operating in the global nuclear medicine & radiopharmaceuticals market. Why Choose This Report - Gain a reliable outlook of the global nuclear medicine & radiopharmaceuticals market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY PRODUCT
  • · Diagnostic radiopharmaceuticals
  • · Therapeutic radiopharmaceuticals
  • PART 6. MARKET BREAKDOWN BY APPLICATION
  • · Bone metastasis
  • · Cardiology
  • · Endocrine tumor
  • · Hyperthyroidism
  • · Lymphoma
  • · Oncology
  • · Others
  • PART 7. MARKET BREAKDOWN BY REGION
  • · Asia Pacific
  • · Europe
  • · North America
  • · Rest of the World (RoW)
  • PART 8. KEY COMPANIES
  • · Australian Nuclear Science and Technology Organisation (ANSTO)
  • · Bracco S.p.A.
  • · Eckert & Ziegler Strahlen- und Medizintechnik AG
  • · ECZACIBASI-MONROL Nuclear Products Co.
  • · IBA Molecular (IBAM)
  • · IRE - IRE ELiT
  • · Jubilant Life Sciences Ltd.
  • · Lantheus Holdings, Inc.
  • · Nordion Inc
  • · NTP Radioisotopes SOC Ltd.
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Nuclear Medicine & Radiopharmaceuticals Market 2022-2028

We are friendly and approachable, give us a call.